Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Geostatistical predictive modeling for asthma and chronic obstructive pulmonary disease using socioeconomic and environmental determinants.

Kumarihamy RMK, Tripathi NK.

Environ Monit Assess. 2019 Jun 28;191(Suppl 2):366. doi: 10.1007/s10661-019-7417-0.

PMID:
31254075
2.

A real-time loop mediated isothermal amplification assay for molecular detection of Burkholderia mallei, the aetiological agent of a zoonotic and re-emerging disease glanders.

Saxena A, Pal V, Tripathi NK, Goel AK.

Acta Trop. 2019 Jun;194:189-194. doi: 10.1016/j.actatropica.2019.04.004. Epub 2019 Apr 5.

PMID:
30958991
3.

Development of a rapid and sensitive recombinase polymerase amplification-lateral flow assay for detection of Burkholderia mallei.

Saxena A, Pal V, Tripathi NK, Goel AK.

Transbound Emerg Dis. 2019 Mar;66(2):1016-1022. doi: 10.1111/tbed.13126. Epub 2019 Feb 15.

PMID:
30650261
4.

Recent Developments in Recombinant Protein-Based Dengue Vaccines.

Tripathi NK, Shrivastava A.

Front Immunol. 2018 Aug 23;9:1919. doi: 10.3389/fimmu.2018.01919. eCollection 2018. Review.

5.

Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.

Saha A, Acharya BN, Priya R, Tripathi NK, Shrivastava A, Rao MK, Kesari P, Narwal M, Tomar S, Bhagyawant SS, Parida M, Dash PK.

Sci Rep. 2018 Jul 17;8(1):10831. doi: 10.1038/s41598-018-29024-2.

6.

Enhanced production and immunological characterization of recombinant West Nile virus envelope domain III protein.

Tripathi NK, Karothia D, Shrivastava A, Banger S, Kumar JS.

N Biotechnol. 2018 Nov 25;46:7-13. doi: 10.1016/j.nbt.2018.05.002. Epub 2018 Jun 5.

PMID:
29768182
7.

Enhanced production and purification of recombinant surface array protein (Sap) for use in detection of Bacillus anthracis.

Puranik N, Tripathi NK, Pal V, Goel AK.

3 Biotech. 2018 May;8(5):254. doi: 10.1007/s13205-018-1269-0. Epub 2018 May 11.

8.

A Diagnostic Approach for Rodent Progressive Cardiomyopathy and Like Lesions in Toxicology Studies up to 28 Days in the Sprague Dawley Rat (Part 2 of 2).

Hailey JR, Maleeff BE, Thomas HC, Pearse G, Klapwijk JC, Cristofori PG, Berridge B, Kimbrough CL, Parker GA, Morton D, Elmore S, Hardisty JF, Dybdal NO, Rehagen DA, Fikes JD, Lamb M, Biddle K, Buetow BS, Carreira V, Nyska A, Tripathi NK, Workman HC, Bienvenu JG, Brees I, Turk JR, Adler RR.

Toxicol Pathol. 2017 Dec;45(8):1055-1066. doi: 10.1177/0192623317743948.

PMID:
29233079
9.

A Diagnostic Approach for Rodent Progressive Cardiomyopathy and Like Lesions in Toxicology Studies up to 28 Days in the Sprague Dawley Rat (Part 1 of 2).

Hailey JR, Maleeff BE, Thomas HC, Pearse G, Klapwijk JC, Cristofori PG, Berridge B, Kimbrough CL, Parker GA, Morton D, Elmore S, Hardisty JF, Dybdal NO, Rehagen DA, Fikes JD, Lamb M, Biddle K, Buetow BS, Carreira V, Nyska A, Tripathi NK, Workman HC, Bienvenu JG, Brees I, Turk JR, Adler RR.

Toxicol Pathol. 2017 Dec;45(8):1043-1054. doi: 10.1177/0192623317743938. Epub 2017 Nov 26.

PMID:
29173114
10.

Working towards dengue as a vaccine-preventable disease: challenges and opportunities.

Shrivastava A, Tripathi NK, Dash PK, Parida M.

Expert Opin Biol Ther. 2017 Oct;17(10):1193-1199. doi: 10.1080/14712598.2017.1356284. Epub 2017 Jul 24. Review.

PMID:
28707486
11.

Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union.

Byrd RA, Owens RA, Blackbourne JL, Coutant DE, Farmen MW, Michael MD, Moyers JS, Schultze AE, Sievert MK, Tripathi NK, Vahle JL.

Regul Toxicol Pharmacol. 2017 Aug;88:56-65. doi: 10.1016/j.yrtph.2017.05.013. Epub 2017 May 17.

PMID:
28526658
12.

Derivatization and interlaminar debonding of graphite-iron nanoparticle hybrid interfaces using Fenton chemistry.

Agarwal N, Bhattacharyya R, Tripathi NK, Kanojia S, Roy D, Mukhopadhyay K, Eswara Prasad N.

Phys Chem Chem Phys. 2017 Jun 28;19(25):16329-16336. doi: 10.1039/c7cp00357a.

PMID:
28429029
13.

Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2.

Tripathi NK, Shrivastava A.

AIMS Microbiol. 2017 Apr 14;3(2):248-266. doi: 10.3934/microbiol.2017.2.248. eCollection 2017.

14.

Principles for Assessing Adversity in Toxicologic Clinical Pathology.

Ramaiah L, Tomlinson L, Tripathi NK, Cregar LC, Vitsky A, Beust BV, Barlow VG, Reagan WJ, Ennulat D.

Toxicol Pathol. 2017 Feb;45(2):260-266. doi: 10.1177/0192623316681646. Epub 2017 Jan 5. Review.

PMID:
28056663
15.
16.

Deciphering Sources of Variability in Clinical Pathology.

Tripathi NK, Everds NE, Schultze AE, Irizarry AR, Hall RL, Provencher A, Aulbach A.

Toxicol Pathol. 2017 Jan;45(1):90-93. doi: 10.1177/0192623316675766. Epub 2016 Nov 1.

PMID:
27803290
17.

STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery Studies.

Tomlinson L, Ramaiah L, Tripathi NK, Barlow VG, Vitsky A, Poitout-Belissent FM, Bounous DI, Ennulat D.

Toxicol Pathol. 2016 Feb;44(2):163-72. doi: 10.1177/0192623315624165. Epub 2016 Feb 14.

PMID:
26879687
18.

A Real-Time Health Monitoring System for Remote Cardiac Patients Using Smartphone and Wearable Sensors.

Kakria P, Tripathi NK, Kitipawang P.

Int J Telemed Appl. 2015;2015:373474. doi: 10.1155/2015/373474. Epub 2015 Dec 15.

19.

Spatial Pattern Detection of Tuberculosis: A Case Study of Si Sa Ket Province, Thailand.

Hassarangsee S, Tripathi NK, Souris M.

Int J Environ Res Public Health. 2015 Dec 17;12(12):16005-18. doi: 10.3390/ijerph121215040.

20.
21.

Mapping urban and peri-urban breeding habitats of Aedes mosquitoes using a fuzzy analytical hierarchical process based on climatic and physical parameters.

Sarfraz MS, Tripathi NK, Faruque FS, Bajwa UI, Kitamoto A, Souris M.

Geospat Health. 2014 Dec 1;8(3):S685-97. doi: 10.4081/gh.2014.297.

22.

Ecosystem evaluation (1989-2012) of Ramsar wetland Deepor Beel using satellite-derived indices.

Mozumder C, Tripathi NK, Tipdecho T.

Environ Monit Assess. 2014 Nov;186(11):7909-27. doi: 10.1007/s10661-014-3976-2. Epub 2014 Aug 5.

PMID:
25092138
23.

Nontraditional applications in clinical pathology.

Jordan HL, Register TC, Tripathi NK, Bolliger AP, Everds N, Zelmanovic D, Poitout F, Bounous DI, Wescott D, Ramaiah SK.

Toxicol Pathol. 2014 Oct;42(7):1058-68. doi: 10.1177/0192623314522109. Epub 2014 Apr 3. Review.

PMID:
24705882
24.

Immunogenicity of Escherichia coli expressed envelope 2 protein of Chikungunya virus.

Tripathi NK, Priya R, Shrivastava A.

Bioengineered. 2014 May-Jun;5(3):198-203. doi: 10.4161/bioe.28336. Epub 2014 Feb 27.

25.

Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®).

Ryan AM, Sokolowski SA, Ng CK, Shirai N, Collinge M, Shen AC, Arrington J, Radi Z, Cummings TR, Ploch SA, Stephenson SA, Tripathi NK, Hurst SI, Finch GL, Leach MW.

Toxicol Pathol. 2014 Oct;42(7):1069-81. doi: 10.1177/0192623313520351. Epub 2014 Mar 6.

PMID:
24604381
26.

Spatio-temporal distribution and hotspots of Hand, Foot and Mouth Disease (HFMD) in northern Thailand.

Samphutthanon R, Tripathi NK, Ninsawat S, Duboz R.

Int J Environ Res Public Health. 2013 Dec 23;11(1):312-36. doi: 10.3390/ijerph110100312.

27.

Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.

Tripathi NK, Priya R, Shrivastava A.

Appl Microbiol Biotechnol. 2014 Mar;98(6):2461-71. doi: 10.1007/s00253-013-5426-4. Epub 2013 Dec 13.

PMID:
24337252
28.

Spatial diffusion of influenza outbreak-related climate factors in Chiang Mai Province, Thailand.

Nakapan S, Tripathi NK, Tipdecho T, Souris M.

Int J Environ Res Public Health. 2012 Oct 24;9(11):3824-42. doi: 10.3390/ijerph9113824.

29.

Analyzing the spatio-temporal relationship between dengue vector larval density and land-use using factor analysis and spatial ring mapping.

Sarfraz MS, Tripathi NK, Tipdecho T, Thongbu T, Kerdthong P, Souris M.

BMC Public Health. 2012 Oct 9;12:853. doi: 10.1186/1471-2458-12-853.

30.

Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.

Tripathi NK, Shrivastava A, Biswal KC, Rao PV.

Appl Microbiol Biotechnol. 2012 Sep;95(5):1179-89. doi: 10.1007/s00253-012-4100-6. Epub 2012 May 6.

PMID:
22562165
31.

Expression, purification and evaluation of diagnostic potential and immunogenicity of dengue virus type 3 domain III protein.

Reddy PB, Pattnaik P, Tripathi NK, Srivastava A, Rao PV.

Protein Pept Lett. 2012 May;19(5):509-19.

PMID:
22486646
32.

Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.

Tripathi NK, Kumar JS, Biswal KC, Rao PV.

Microb Biotechnol. 2012 Sep;5(5):599-606. doi: 10.1111/j.1751-7915.2012.00344.x. Epub 2012 Mar 27.

33.

Estimation of the effect of soil texture on nitrate-nitrogen content in groundwater using optical remote sensing.

Witheetrirong Y, Tripathi NK, Tipdecho T, Parkpian P.

Int J Environ Res Public Health. 2011 Aug;8(8):3416-36. doi: 10.3390/ijerph8083416. Epub 2011 Aug 19.

34.

Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.

Tripathi NK, Schultze AE, Pearson RC, Everds NE, Elliott GS, Ramaiah L, Wells MY, Latimer KS, Walter GL, Katavolos P, Collins ND, Tarrant J, Walker DB, Topper MJ, Jordan HL, O'Rourke LG, Guilpin VB, Brockus CW, Wilcox AL, Clemo FA, Smith GS, Reagan WJ, McCartney JE.

Exp Toxicol Pathol. 2013 Jan;65(1-2):39. doi: 10.1016/j.etp.2011.05.007. Epub 2011 Jun 15. No abstract available.

PMID:
21676604
35.

Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.

Tripathi NK, Shrivastava A, Biswal KC, Rao PV.

Biotechnol J. 2011 May;6(5):604-8. doi: 10.1002/biot.201000399. Epub 2011 Feb 9.

PMID:
21538895
36.

Spatio-temporal diffusion pattern and hotspot detection of dengue in Chachoengsao province, Thailand.

Jeefoo P, Tripathi NK, Souris M.

Int J Environ Res Public Health. 2011 Jan;8(1):51-74. doi: 10.3390/ijerph8010051. Epub 2010 Dec 29.

37.

Evaluation of a commercial Dengue NS1 enzyme-linked immunosorbent assay for early diagnosis of dengue infection.

Shrivastava A, Dash PK, Tripathi NK, Sahni AK, Gopalan N, Lakshmana Rao PV.

Indian J Med Microbiol. 2011 Jan-Mar;29(1):51-5. doi: 10.4103/0255-0857.76525.

38.
39.

Detection of dengue virus.

Tripathi NK, Shrivastava A, Dash PK, Jana AM.

Methods Mol Biol. 2011;665:51-64. doi: 10.1007/978-1-60761-817-1_4.

PMID:
21116795
40.

Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.

Tripathi NK, Shukla J, Biswal KC, Lakshmana Rao PV.

Appl Microbiol Biotechnol. 2010 May;86(6):1795-803. doi: 10.1007/s00253-010-2488-4. Epub 2010 Feb 23.

PMID:
20177885
41.

Exploring spatial patterns and hotspots of diarrhea in Chiang Mai, Thailand.

Chaikaew N, Tripathi NK, Souris M.

Int J Health Geogr. 2009 Jun 24;8:36. doi: 10.1186/1476-072X-8-36.

42.

GIS-based analysis of the fate of waste-related pathogens Cryptosporidium parvum, Giardia lamblia and Escherichia coli in a tropical canal network.

Diallo MB, Anceno AJ, Tawatsupa B, Tripathi NK, Wangsuphachart V, Shipin OV.

J Water Health. 2009 Mar;7(1):133-43. doi: 10.2166/wh.2009.010.

PMID:
18957782
43.

Comparison of a dipstick enzyme-linked immunosorbent assay with commercial assays for detection of Japanese encephalitis virus-specific IgM antibodies.

Shrivastva A, Tripathi NK, Parida M, Dash PK, Jana AM, Lakshmana Rao PV.

J Postgrad Med. 2008 Jul-Sep;54(3):181-5.

44.

Production and characterization of recombinant dengue virus type 4 envelope domain III protein.

Tripathi NK, Babu JP, Shrivastva A, Parida M, Jana AM, Rao PV.

J Biotechnol. 2008 Apr 30;134(3-4):278-86. doi: 10.1016/j.jbiotec.2008.02.001. Epub 2008 Feb 13.

PMID:
18342971
45.

East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India.

Dash PK, Parida MM, Santhosh SR, Verma SK, Tripathi NK, Ambuj S, Saxena P, Gupta N, Chaudhary M, Babu JP, Lakshmi V, Mamidi N, Subhalaxmi MV, Lakshmana Rao PV, Sekhar K.

Vector Borne Zoonotic Dis. 2007 Winter;7(4):519-27. doi: 10.1089/vbz.2007.7272.

PMID:
18171110
46.

Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of Chikungunya virus.

Santhosh SR, Parida MM, Dash PK, Pateriya A, Pattnaik B, Pradhan HK, Tripathi NK, Ambuj S, Gupta N, Saxena P, Lakshmana Rao PV.

J Clin Virol. 2007 Jul;39(3):188-93. Epub 2007 Jun 5.

PMID:
17553740
47.

Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantitation of Japanese encephalitis virus.

Santhosh SR, Parida MM, Dash PK, Pateriya A, Pattnaik B, Pradhan HK, Tripathi NK, Ambuj S, Gupta N, Saxena P, Lakshmana Rao PV.

J Virol Methods. 2007 Jul;143(1):73-80. Epub 2007 Apr 2.

PMID:
17403544
48.

Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection.

Tripathi NK, Shrivastva A, Pattnaik P, Parida M, Dash PK, Gupta N, Jana AM, Rao PV.

Biotechnol Prog. 2007 Mar-Apr;23(2):488-93. Epub 2007 Jan 27.

PMID:
17256968
49.

Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay.

Parida MM, Santhosh SR, Dash PK, Tripathi NK, Lakshmi V, Mamidi N, Shrivastva A, Gupta N, Saxena P, Babu JP, Rao PV, Morita K.

J Clin Microbiol. 2007 Feb;45(2):351-7. Epub 2006 Nov 29.

50.

Japanese Encephalitis Outbreak, India, 2005.

Parida M, Dash PK, Tripathi NK, Ambuj, Sannarangaiah S, Saxena P, Agarwal S, Sahni AK, Singh SP, Rathi AK, Bhargava R, Abhyankar A, Verma SK, Rao PV, Sekhar K.

Emerg Infect Dis. 2006 Sep;12(9):1427-30.

Supplemental Content

Loading ...
Support Center